Innovative cancer therapy through Myc inhibition: taking OMO-103 to market

Project description

A novel cancer therapy penetrates cancer cell nuclei to reach their Achilles heel

Fields of science

• medical and health sciences › clinical medicine › oncology › lung cancer
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs
• humanities › languages and literature › linguistics › phonetics

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

PEPTOMYC SL

Address

Center Cellex, Calle Natzaret 115-117
08035 Barcelona
Spain

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 2 219 553,52